ESR1 and endometrial carcinoma: Across a cancer study subset of 29 primary endometrial carcinomas that had gone on to metastasize, we characterized the copy-number changes by GeneChips and validated amplifications of ESR1 in these cancers by fluorescence in-situ hybridization (FISH).